Literature DB >> 1115575

Diagnostic criteria and five-year outcome in schizophrenia. A report from the International Pilot Study of schizophrenia.

A B Hawk, W T Carpenter, J S Strauss.   

Abstract

Systematic psychiatric assessment was undertaken on 131 patients (the American cohort of the International Pilot Study of Schizophrenia). Nine areas of outcome functioning were assessed five years later at follow-up evaluation on 63% of these patients. An analysis of 66 clinical and demographic variables established that the patients sucessfully followed-up were representatives of the entire cohort. Diagnostic data from initial evaluations and follow-up outcome assessment were used to examine the relationship between diagnostic criteria and outcome in schizophrenia. Applying the criteria for schizophrenic diagnosis defined by Langfeldt, by Schneider, and Carpenter et al failed to define a poor outcome group. No difference in outcome was found when traditional schizophrenic subtypes were contrasted. Overall outcome in 61 patients with conditions diagnosed as schizophrenic was heterogeneous. However, despite overlap, the mean outcome in the schizophrenic cohort was poorer than in the 19 nonschizophrenic patients.

Entities:  

Mesh:

Year:  1975        PMID: 1115575     DOI: 10.1001/archpsyc.1975.01760210077005

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


  56 in total

1.  Are Negative Symptoms Dimensional or Categorical? Detection and Validation of Deficit Schizophrenia With Taxometric and Latent Variable Mixture Models.

Authors:  Anthony O Ahmed; Gregory P Strauss; Robert W Buchanan; Brian Kirkpatrick; William T Carpenter
Journal:  Schizophr Bull       Date:  2014-11-14       Impact factor: 9.306

2.  Control of working memory content in schizophrenia.

Authors:  Britta Hahn; Andrew Hollingworth; Benjamin M Robinson; Samuel T Kaiser; Carly J Leonard; Valerie M Beck; Emily S Kappenman; Steven J Luck; James M Gold
Journal:  Schizophr Res       Date:  2011-11-12       Impact factor: 4.939

Review 3.  Revisiting the diagnosis of schizophrenia: where have we been and where are we going?

Authors:  William R Keller; Bernard A Fischer; William T Carpenter
Journal:  CNS Neurosci Ther       Date:  2010-12-27       Impact factor: 5.243

4.  Neurophysiological evidence for emotion regulation impairment in schizophrenia: The role of visual attention and cognitive effort.

Authors:  Lisa A Bartolomeo; Adam J Culbreth; Kathryn L Ossenfort; Gregory P Strauss
Journal:  J Abnorm Psychol       Date:  2020-06-11

5.  Identifying unmet therapeutic domains in schizophrenia patients: the early contributions of Wayne Fenton from Chestnut Lodge.

Authors:  Thomas H McGlashan; William T Carpenter
Journal:  Schizophr Bull       Date:  2007-07-18       Impact factor: 9.306

6.  Remission in schizophrenia: the relationship to baseline symptoms and changes in symptom domains during a one-year study.

Authors:  D L Kelly; E Weiner; M P Ball; R P McMahon; W T Carpenter; R W Buchanan
Journal:  J Psychopharmacol       Date:  2008-06-26       Impact factor: 4.153

7.  The Prognostic Scale by Strauss and Carpenter and its validity.

Authors:  M Händel; J Bailer; W Bräuer; D Laubenstein; E R Rey
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1996       Impact factor: 5.270

8.  One hundred years.

Authors:  William T Carpenter
Journal:  Schizophr Bull       Date:  2011-05       Impact factor: 9.306

9.  Deconstructing negative symptoms of schizophrenia: avolition-apathy and diminished expression clusters predict clinical presentation and functional outcome.

Authors:  Gregory P Strauss; William P Horan; Brian Kirkpatrick; Bernard A Fischer; William R Keller; Pinar Miski; Robert W Buchanan; Michael F Green; William T Carpenter
Journal:  J Psychiatr Res       Date:  2013-02-27       Impact factor: 4.791

10.  The special treatment of first rank auditory hallucinations and bizarre delusions in the diagnosis of schizophrenia.

Authors:  Ann K Shinn; Stephan Heckers; Dost Öngür
Journal:  Schizophr Res       Date:  2013-03-22       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.